Clinical outcomes and quality of life in children and adolescents with primary brain tumors treated with pencil beam scanning proton therapy
Sébastien Tran(University Hospital of Geneva), Damien C. Weber(University Hospital of Geneva), Stefan Zepter(Paul Scherrer Institute), C. Teske(University Hospital Münster), Beate Timmermann(Essen University Hospital), Katja Baust(University Hospital Bonn), Beat Bojaxhiu(University of Bern), Gabriele Calaminus(University Hospital Bonn), Ulrike Kliebsch(Paul Scherrer Institute), Pei Lim(University College Hospital)
Cited by 29
Related Papers
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419